Katalog Plus
Bibliothek der Frankfurt UAS
Bald neuer Katalog: sichern Sie sich schon vorab Ihre persönlichen Merklisten im Nutzerkonto: Anleitung.
Dieses Ergebnis aus BASE kann Gästen nicht angezeigt werden.  Login für vollen Zugriff.

The impact of implementing a Xpert MTB/RIF algorithm on drug-sensitive pulmonary tuberculosis: a retrospective analysis

Title: The impact of implementing a Xpert MTB/RIF algorithm on drug-sensitive pulmonary tuberculosis: a retrospective analysis
Authors: Rees, K.; Muditambi, N.; Maswanganyi, M.; Railton, J.; Mcintyre, J. A.; Struthers, H. E.; Fourie, P. B.; Peters, R. P. H.
Source: Rees, K, Muditambi, N, Maswanganyi, M, Railton, J, Mcintyre, J A, Struthers, H E, Fourie, P B & Peters, R P H 2018, 'The impact of implementing a Xpert MTB/RIF algorithm on drug-sensitive pulmonary tuberculosis: a retrospective analysis', Epidemiology and Infection, vol. 146, no. 2, pp. 246-255. https://doi.org/10.1017/S0950268817002746
Publication Year: 2018
Collection: Maastricht University Research Publications
Subject Terms: Diagnostic trend; HIV; tuberculosis; Xpert; CASE NOTIFICATION RATES; SOUTH-AFRICA; ANTIRETROVIRAL THERAPY; ROLL-OUT; SCALE-UP; ART; TB; MORTALITY; PROGRAMS; ACCURACY
Description: Xpert MTB/RIF (Xpert) is the preferred first-line test for all persons with tuberculosis (TB) symptoms in South Africa in line with a diagnostic algorithm. This study evaluates pre- and post-implementation trends in diagnostic practices for drug-sensitive, pulmonary TB in adults in an operational setting, following the introduction of the Xpert-based algorithm. We retrospectively analysed data from the national TB database for Greater Tzaneen sub-district, Limpopo Province. Trends in a number of cases, diagnosis and outcome and characteristics associated with death are reported. A total of 8407 cases were treated from 2008 until 2015, with annual cases registered decreasing by 31.7% over that time period (from 1251 to 855 per year). After implementation of Xpert, 69.9% of cases were diagnosed by Xpert, 29.4% clinically, 0.6% by smear microscopy and 0.1% by culture. Cases with a recorded microbiological test increased from 76.2% to 96.4%. Cases started on treatment without confirmation, but with a negative microbiological test increased from 7.1% to 25.7%. Case fatality decreased from 15.0% to 9.8%, remaining consistently higher in empirically treated groups, regardless of HIV status. Implementation of the algorithm coincided with a reduced number of TB cases treated and improved coverage of microbiological testing; however, a substantial proportion of cases continued to start treatment empirically.
Document Type: article in journal/newspaper
Language: English
ISSN: 0950-2688; 1469-4409
Relation: info:eu-repo/semantics/altIdentifier/pmid/29208074; info:eu-repo/semantics/altIdentifier/wos/000423547900012; info:eu-repo/semantics/altIdentifier/pissn/0950-2688; info:eu-repo/semantics/altIdentifier/eissn/1469-4409
DOI: 10.1017/S0950268817002746
Availability: https://cris.maastrichtuniversity.nl/en/publications/503b5af7-062f-46d0-8a5d-bb218e318412; https://doi.org/10.1017/S0950268817002746; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9134741
Rights: info:eu-repo/semantics/openAccess
Accession Number: edsbas.4FF2F9C3
Database: BASE